Skip to main content
. 2019 Nov 12;68(12):2067–2080. doi: 10.1007/s00262-019-02429-2

Fig. 3.

Fig. 3

Patients with high-Gal-9+TAMs exhibit prominent adjuvant chemotherapy effectiveness. Kaplan–Meier analyses for OS and RFS of a, b all patients, c, d high-Gal-9+TAM patients and e, f low-Gal-9+TAM patients with or without ACT. Univariate and multivariate Cox regression analyses for ACT benefit on g OS and h RFS among different clinico-pathological variables